Secondary prevention of stroke: Old and new evidence

[1]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[2]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[3]  G. Schillaci,et al.  [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[4]  B Neal,et al.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.

[5]  S. MacMahon,et al.  PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. , 2000, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[6]  G. Hankey,et al.  Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations* , 1999, The Lancet.

[7]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[8]  A. Algra,et al.  Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin , 1999, Journal of neurology, neurosurgery, and psychiatry.

[9]  Z. Li,et al.  Blood pressure, cholesterol, and stroke in eastern Asia , 1998, The Lancet.

[10]  D. Moher,et al.  Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis , 1998, BMJ.

[11]  D. Sackett,et al.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.

[12]  S. Pocock,et al.  Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. , 1997, Stroke.

[13]  J. Staessen.  Potential adverse effects of blood pressure lowering—J-curve revisited , 1996, The Lancet.

[14]  J. Slattery,et al.  Blood pressure and risk of stroke in patients with cerebrovascular disease , 1996, BMJ.

[15]  D. Kromhout.  Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.

[16]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[17]  L. Wilkins.  Trial of Secondary Prevention With Atenolol After Transient Ischemic Attack or Nondisabling Ischemic Stroke , 1993, Stroke.

[18]  Ruth Bonita,et al.  Epidemiology of stroke , 1992, The Lancet.

[19]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[20]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[21]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[22]  A. Carter,et al.  Hypotensive therapy in stroke survivors. , 1970, Lancet.

[23]  C. Anderson,et al.  Blood Pressure Lowering for the Prevention of Cognitive Decline in Patients with Cerebrovascular Disease , 1997 .

[24]  F. Gueyffier,et al.  New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. , 1996, Journal of human hypertension.

[25]  R. Collins,et al.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.